PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of springeropenLink to Publisher's site
The International Journal of Cardiovascular Imaging
 
Int J Cardiovasc Imaging. 2010 June; 26(5): 601–604.
Published online 2010 April 16. doi:  10.1007/s10554-010-9628-x
PMCID: PMC2868173

Increased accuracy in computed tomography coronary angiography; a new body surface area adapted protocol

Amongst the advanced cardiac imaging modalities, multi detector computed tomography coronary angiography (CTCA) has emerged as a reliable non-invasive method for the assessment of coronary anatomy, coronary artery disease, and cardiac function [116]. Multiple studies involving over several thousands of patients have established that CTCA is highly accurate for delineation of the presence and severity of coronary atherosclerosis [9, 1729]. CTCA may also reveal the total plaque burden, i.e., both calcified and non-calcified components, for individual patients with coronary atherosclerosis [3039].

The advent of prospectively gated acquisition techniques for 64-slice CTCA has allowed a significant reduction in dose exposure [4043]. Consequently, a combined approach of CTCA and myocardial perfusion imaging with CTCA angiography might potentially become feasible at a total radiation dose of much less than 10 mSv, particularly for the assessment of patients with established coronary artery disease, who are likely to have diffuse calcification [4452]. In routine CTCA acquisitions, there might be a considerable signal density drop at the posterobasal wall resembling perfusion defects possibly being attributed to beam hardening artifacts [53] Beam hardening artifacts may be a common finding at CTCA of asymptomatic patients affecting predominantly the posterobasal wall, reducing the accuracy of CTCA. Also coronary vessel attenuation may affect the accuracy of CTCA as for an accurate detection of coronary plaque an appropriate amount of contrast material is needed. Coronary blooming artifacts caused by too large contract material amounts may hamper the detection of coronary plaque. The attenuation of coronary vessels is influenced by the individual patient’s weight and height which are expressed by body mass index and body surface area (BSA) Attenuation of coronary vessels in CTCA is closely related to several factors including both patient specific characteristics such as body mass, blood volume and cardiac output and protocol-related parameters such as concentration and injection rate of the administered contrast material.

In patients with increased body mass CTCA image quality is degraded by an unfavorable shift in the signal-to-noise ratio due to increase in noise and loss of attenuation. Introduction of scan protocols with body mass index-adapted tube current and voltage have allowed handling the adverse effects of body mass on image noise. Therefore, BSA would be the most promising parameter to be used for contrast protocol adjustment. An ideal protocol should integrate both body mass index adaptation of tube parameters (noise minimization) and contrast material adjustment according to BSA (signal optimization). This may help differentiating coronary plaque from surrounding tissue and avoid blooming artifacts caused by intracoronary contrast material concentration. In patients with a large total blood volume, contrast material dilution decreases coronary attenuation in CTCA. In addition, increased blood volume is well paralleled by BSA.

In the current issue of the International Journal of Cardiovascular Imaging, Pazhenkottil et al. [54], using low-dose CTCA with prospective ECG-triggering, evaluated a BSA-adapted contrast material protocol to compensate for dilution effects in 80 patients with a BSA-adapted contrast material bolus ranging 40–105 ml and injection rate ranging 3.5–5.0 ml/s for a BSA of <1.70 m² to ≥2.50 m². A total of 80 controls matched for BSA who had previously undergone routine CTCA with a fixed contrast material protocol of 80 ml at 5 ml/s served as reference group. The average vessel attenuation from both the proximal right coronary artery and the left main coronary artery was assessed. Correlation of BSA with vessel attenuation was assessed in both groups. Interestingly, the authors found that BSA-matching was successful in all patients (BSA-adapted group 1.98 ± 0.15 m² versus the reference group 1.98 ± 0.17 m²). Mean contrast material bolus was significantly smaller in the BSA-adapted versus the reference group (mean 70 ml vs. mean 80 ml). There was no correlation in the BSA-adapted group, while coronary attenuation was significantly inversely related to BSA in the reference group. It was concluded that a BSA-adapted contrast material protocol successfully results in a comparable coronary contrast enhancement independent of individual BSA. This was achieved despite a significant reduction in the overall contrast material amount. The findings of the present study therefore clearly show that the BSA-adapted contrast material administration protocol is feasible and successful as the inverse correlation between BSA and coronary attenuation found in the control group could be abolished. As a result, range and standard deviation of coronary attenuation were smaller in the BSA-adapted group compared to the control group, indicating a well-balanced consistent contrast enhancement throughout a large range of BSA. Furthermore, by using the BSA-adapted protocol a significantly lower average amount of contrast medium was injected, which may help preventing contrast induced nephropathy and its consequences.

Previous studies [5558] from the same group directed by Kaufmann had already shown that the use of the proposed body mass index-adapted scanning parameters results in similar image noise regardless of body mass index. Tatsugami et al. [55] initially showed that an increased bolus dilution due to larger blood volume may account for the decrease in contrast-to-noise ratio and vessel attenuation in patients with higher body mass index, but in this study the contrast bolus was not adapted to body mass index. Herzog et al. [56] showed that, after successfully overcoming the impact of body mass index on image noise by adapting tube parameters, the contrast to noise ratio mainly depends on coronary vessel contrast. The latter reflects the dilution of the contrast material by blood volume and cardiac output, which are both correlated to BSA. Therefore, BSA-adapted contrast administration may help to compensate for this effect. Husman et al. [57, 58] recently reported that a BMI-adapted contrast material protocol results in adequate coronary vessel attenuation independent of individual body mass index despite a significant reduction in overall amount of contrast material used.

To summarize, the current study validly extends previous findings that the proposed BSA-adapted contrast material protocol in patients undergoing low-dose CTCA results in adequate coronary vessel attenuation independent of individual BSA.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Footnotes

Editorial comment on to the article of Pazhenkottil et al. (doi: 10.1007/s10554-010-9594-3).

References

1. Werkhoven JM, Schuijf JD, Jukema JW, et al. Anatomic correlates of a normal perfusion scan using 64-slice computed tomographic coronary angiography. Am J Cardiol. 2008;101:40–45. doi: 10.1016/j.amjcard.2007.07.046. [PubMed] [Cross Ref]
2. Schuijf JD, Bax JJ, Wall EE. Anatomical and functional imaging techniques: basically similar or fundamentally different? Neth Heart J. 2007;15:43–44. [PMC free article] [PubMed]
3. Scholte AJ, Bax JJ, Wackers FJ. Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: combined use of stress myocardial perfusion imaging and coronary calcium scoring. J Nucl Cardiol. 2006;13:11–18. doi: 10.1016/j.nuclcard.2005.11.002. [PubMed] [Cross Ref]
4. Wijpkema JS, Dorgelo J, Willems TP, et al. Discordance between anatomical and functional coronary stenosis severity. Neth Heart J. 2007;15:5–11. [PMC free article] [PubMed]
5. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol. 2004;94:1506–1509. doi: 10.1016/j.amjcard.2004.08.028. [PubMed] [Cross Ref]
6. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction; joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Eur Heart J. 2007;28:2525–2538. doi: 10.1093/eurheartj/ehm355. [PubMed] [Cross Ref]
7. Lennep JE, Westerveld HT, Lennep HW, Zwinderman AH, Erkelens DW, Wall EE. Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol. 2000;20:2408–2413. [PubMed]
8. Chamuleau SA, Vrijsen KR, Rokosh DG, Tang XL, Piek JJ, Bolli R. Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J. 2009;17:199–207. [PMC free article] [PubMed]
9. Leeuw JG, Wardeh A, Sramek A, Wall EE. Pseudo-aortic dissection after primary PCI. Neth Heart J. 2007;15:265–266. [PMC free article] [PubMed]
10. Braun S, Wall EE, Emanuelsson S, Kobrin I. Effects of a new calcium antagonist, mibefradil (Ro 40–5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The mibefradil international study group. J Am Coll Cardiol. 1996;27:317–322. doi: 10.1016/0735-1097(95)00472-6. [PubMed] [Cross Ref]
11. Portegies MC, Schmitt R, Kraaij CJ, et al. Lack of negative inotropic effects of the new calcium antagonist Ro 40–5967 in patients with stable angina pectoris. J Cardiovasc Pharmacol. 1991;18:746–751. doi: 10.1097/00005344-199111000-00013. [PubMed] [Cross Ref]
12. ten Kate GJ, Wuestink AC, Feyter PJ. Coronary artery anomalies detected by MSCT-angiography in the adult. Neth Heart J. 2008;16:369–375. [PMC free article] [PubMed]
13. Schuijf JD, Jukema JW, Wall EE, Bax JJ. Multi-slice computed tomography in the evaluation of patients with acute chest pain. Acute Card Care. 2007;9:214–221. doi: 10.1080/17482940701589275. [PubMed] [Cross Ref]
14. Groen JM, Greuter MJ, Vliegenthart R, et al. Calcium scoring using 64-slice MDCT, dual source CT and EBT: a comparative phantom study. Int J Cardiovasc Imaging. 2008;24:547–556. doi: 10.1007/s10554-007-9282-0. [PMC free article] [PubMed] [Cross Ref]
15. Bavelaar-Croon CD, Pauwels EK, Wall EE. Gated single-photon emission computed tomographic myocardial imaging: a new tool in clinical cardiology. Am Heart J. 2001;141:383–390. doi: 10.1067/mhj.2001.112780. [PubMed] [Cross Ref]
16. Wall EE, Heidendal GA, Hollander W, Westera G, Roos JP. I-123 labeled hexadecenoic acid in comparison with thallium-201 for myocardial imaging in coronary heart disease. A preliminary study. Eur J Nucl Med. 1980;5:401–405. doi: 10.1007/BF00261781. [PubMed] [Cross Ref]
17. Bax JJ, Lamb H, Dibbets P, et al. Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol. 2000;86:1299–1305. doi: 10.1016/S0002-9149(00)01231-5. [PubMed] [Cross Ref]
18. Chamuleau SA, Eck-Smit BL, Meuwissen M, et al. Long-term prognostic value of CFVR and FFR versus perfusion scintigraphy in patients with multivessel disease. Neth Heart J. 2007;15:369–374. [PMC free article] [PubMed]
19. Bavelaar-Croon CD, Kayser HW, Wall EE, et al. Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology. 2000;217:572–575. [PubMed]
20. Wall EE, Hollander W, Heidendal GA, Westera G, Majid PA, Roos JP. Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med. 1981;6:383–389. [PubMed]
21. Wall EE, Dijkman PR, Roos A, et al. Diagnostic significance of gadolinium-DTPA (diethylene- triamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: its potential in assessing reperfusion. Br Heart J. 1990;63:12–17. doi: 10.1136/hrt.63.1.12. [PMC free article] [PubMed] [Cross Ref]
22. Dijkman PR, Wall EE, Roos A, et al. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology. 1991;180:147–151. [PubMed]
23. Roos A, Matheijssen NA, Doornbos J, Dijkman PR, Voorthuisen AE, Wall EE. Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology. 1990;176:517–521. [PubMed]
24. Pluim BM, Lamb HJ, Kayser HW, et al. Functional and metabolic evaluation of the athlete’s heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 1998;97:666–672. [PubMed]
25. Rugge FP, Boreel JJ, Wall EE, et al. Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:959–965. [PubMed]
26. Geest RJ, Roos A, Wall EE, Reiber JH. Quantitative analysis of cardiovascular MR images. Int J Card Imaging. 1997;13:247–258. doi: 10.1023/A:1005869509149. [PubMed] [Cross Ref]
27. Geest RJ, Niezen RA, Wall EE, Roos A, Reiber JH. Automated measurement of volume flow in the ascending aorta using MR velocity maps: evaluation of inter- and intraobserver variability in healthy volunteers. J Comput Assist Tomogr. 1998;22:904–911. doi: 10.1097/00004728-199811000-00013. [PubMed] [Cross Ref]
28. Wall EE, Vliegen HW, Roos A, Bruschke AV. Magnetic resonance imaging in coronary artery disease. Circulation. 1995;92:2723–2739. [PubMed]
29. Bleeker GB, Bax JJ, Fung JW, et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97:260–263. doi: 10.1016/j.amjcard.2005.08.030. [PubMed] [Cross Ref]
30. Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006;48:2243–2250. doi: 10.1016/j.jacc.2006.07.067. [PubMed] [Cross Ref]
31. Ypenburg C, Wall EE, Schalij MJ, Bax JJ. Imaging in cardiac resynchronisation therapy. Neth Heart J. 2008;16:S36–S40. [PMC free article] [PubMed]
32. Ypenburg C, Roes SD, Bleeker GB, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007;99:657–660. doi: 10.1016/j.amjcard.2006.09.115. [PubMed] [Cross Ref]
33. Ypenburg C, Schalij MJ, Bleeker GB, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33–41. doi: 10.1093/eurheartj/ehl379. [PubMed] [Cross Ref]
34. Vliegen HW, Doornbos J, Roos A, Jukema JW, Bekedam MA, Wall EE. Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol. 1997;79:773–776. doi: 10.1016/S0002-9149(96)00866-1. [PubMed] [Cross Ref]
35. Hoogendoorn LI, Pattynama PM, Buis B, Geest RJ, Wall EE, Roos A. Noninvasive evaluation of aortocoronary bypass grafts with magnetic resonance flow mapping. Am J Cardiol. 1995;75:845–848. doi: 10.1016/S0002-9149(99)80429-9. [PubMed] [Cross Ref]
36. Holman ER, Buller VG, Roos A, et al. Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation. 1997;95:924–931. [PubMed]
37. Bakx AL, Wall EE, Braun S, Emanuelsson H, Bruschke AV, Kobrin I. Effects of the new calcium antagonist mibefradil (Ro 40–5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40–5967 International Study Group. Am Heart J. 1995;130:748–757. doi: 10.1016/0002-8703(95)90073-X. [PubMed] [Cross Ref]
38. Schuijf JD, Pundziute G, Jukema JW, et al. Diagnostic accuracy of 64-slice multislice computed tomography in the noninvasive evaluation of significant coronary artery disease. Am J Cardiol. 2006;98:145–148. doi: 10.1016/j.amjcard.2006.01.092. [PubMed] [Cross Ref]
39. Jongbloed MR, Lamb HJ, Bax JJ, et al. Noninvasive visualization of the cardiac venous system using multislice computed tomography. J Am Coll Cardiol. 2005;45:749–753. doi: 10.1016/j.jacc.2004.11.035. [PubMed] [Cross Ref]
40. Schuijf JD, Wijns W, Jukema JW, et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol. 2006;48:2508–2514. doi: 10.1016/j.jacc.2006.05.080. [PubMed] [Cross Ref]
41. Pundziute G, Schuijf JD, Jukema JW, et al. Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;49:62–70. doi: 10.1016/j.jacc.2006.07.070. [PubMed] [Cross Ref]
42. Henneman MM, Schuijf JD, Pundziute G, et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol. 2008;52:216–222. doi: 10.1016/j.jacc.2008.04.012. [PubMed] [Cross Ref]
43. Nooijer R, Verkleij CJ, der Thüsen JH, et al. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol. 2006;26:340–346. doi: 10.1161/01.ATV.0000197795.56960.64. [PubMed] [Cross Ref]
44. Laarse A, Kerkhof PL, Vermeer F, et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol. 1988;61:1–7. doi: 10.1016/0002-9149(88)91294-5. [PubMed] [Cross Ref]
45. Hoeven BL, Pires NM, Warda HM, et al. Drug-eluting stents: results, promises and problems. Int J Cardiol. 2005;99:9–17. doi: 10.1016/j.ijcard.2004.01.021. [PubMed] [Cross Ref]
46. Ertaş G, Beusekom HM, Giessen WJ. Late stent thrombosis, endothelialisation and drug-eluting stents. Neth Heart J. 2009;17:177–180. [PMC free article] [PubMed]
47. Tops LF, Bax JJ, Zeppenfeld K, et al. Fusion of multislice computed tomography imaging with three-dimensional electroanatomic mapping to guide radiofrequency catheter ablation procedures. Heart Rhythm. 2005;2:1076–1081. doi: 10.1016/j.hrthm.2005.07.019. [PubMed] [Cross Ref]
48. Marques KM, Westerhof N. Characteristics of the flow velocity-pressure gradient relation in the assessment of stenoses: an in vitro study. Neth Heart J. 2008;16:156–162. [PMC free article] [PubMed]
49. Sirineni GK, Raggi P, Shaw LJ, Stillman AE. Calculation of coronary age using calcium scores in multiple ethnicities. Int J Cardiovasc Imaging. 2008;24:107–111. doi: 10.1007/s10554-007-9233-9. [PubMed] [Cross Ref]
50. Wall EE. CT angiography, underuse, overuse, or appropriate use? Neth Heart J. 2009;17:223. [PMC free article] [PubMed]
51. Mieghem CA, Feyter PJ. Combining noninvasive anatomical imaging with invasive functional information: an unconventional but appropriate hybrid approach. Neth Heart J. 2009;17:292–294. [PMC free article] [PubMed]
52. Knaapen P, Haan S, Hoekstra OS, et al. Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Neth Heart J. 2010;18:90–98. [PMC free article] [PubMed]
53. Rodríguez-Granillo GA, Rosales MA, Degrossi E, Rodriguez AE (2009, Nov 12) Signal density of left ventricular myocardial segments and impact of beam hardening artifact: implications for myocardial perfusion assessment by multidetector CT coronary angiography. Int J Cardiovasc Imaging [Epub ahead of print] [PubMed]
54. Pazhenkottil AP, Husmann L, Buechel RR et al. (2010, Feb 4) Validation of a new contrast material protocol adapted to body surface area for optimized low-dose CT coronary angiography with prospective ECG-triggering. Int J Cardiovasc Imaging [Epub ahead of print] [PubMed]
55. Tatsugami F, Husmann L, Herzog BA, et al. Evaluation of a body mass index-adapted protocol for low-dose 64-MDCT coronary angiography with prospective ECG triggering. AJR Am J Roentgenol. 2009;192:635–638. doi: 10.2214/AJR.08.1390. [PubMed] [Cross Ref]
56. Herzog BA, Husmann L, Valenta I, et al. Determinants of vessel contrast in BMI-adapted low dose CT coronary angiography with prospective ECG-triggering. Int J Cardiovasc Imaging. 2009;25:625–630. doi: 10.1007/s10554-009-9460-3. [PubMed] [Cross Ref]
57. Husmann L, Tatsugami F, Aepli U, et al. Prevalence of noncardiac findings on low dose 64-slice computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT. Int J Cardiovasc Imaging. 2009;25:859–865. doi: 10.1007/s10554-009-9490-x. [PubMed] [Cross Ref]
58. Husmann L, Herzog BA, Burkhard N, et al. Low-dose coronary CT angiography with prospective ECG triggering: validation of a contrast material protocol adapted to body mass index. AJR Am J Roentgenol. 2009;193:802–806. doi: 10.2214/AJR.08.2052. [PubMed] [Cross Ref]

Articles from Springer Open Choice are provided here courtesy of Springer